<?xml version="1.0" encoding="UTF-8"?>
<ref id="mdx698-B14">
 <label>14</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Aapro</surname>
    <given-names>M</given-names>
   </name>, 
   <name name-style="western">
    <surname>Karthaus</surname>
    <given-names>M</given-names>
   </name>, 
   <name name-style="western">
    <surname>Schwartzberg</surname>
    <given-names>L</given-names>
   </name>
  </person-group>
  <etal/>
  <article-title>NEPA, a fixed oral combination of netupitant and palonosetron, improves control of chemotherapy-induced nausea and vomiting (CINV) over multiple cycles of chemotherapy: results of a randomized, double-blind, phase 3 trial versus oral palonosetron</article-title>. 
  <source>Support Care Cancer</source>
  <year>2017</year>; 
  <volume>25</volume>(
  <issue>4</issue>): 
  <fpage>1127</fpage>â€“
  <lpage>1135</lpage>.
  <pub-id pub-id-type="pmid">27885469</pub-id>
 </mixed-citation>
</ref>
